BiotechTube
Home/Avalyn Pharmaceuticals/Doug Carlson
DC

Doug Carlson

Chief Financial Officer and Chief Business Officer

Avalyn Pharmaceuticals

Therapeutic Areas

Pulmonary FibrosisInterstitial Lung DiseasesRare Respiratory Diseases

Avalyn Pharmaceuticals Pipeline

DrugIndicationPhase
AP01Idiopathic Pulmonary Fibrosis (IPF) & Progressive Pulmonary Fibrosis (PPF)Phase 2
AP02Idiopathic Pulmonary Fibrosis (IPF)Phase 2
AP03Interstitial Lung Disease (ILD)Preclinical

Leadership Team at Avalyn Pharmaceuticals

LB
Lyn Baranowski
Chief Executive Officer
MR
Melissa Rhodes
Chief Operating Officer
HM
Howard M. Lazarus
Chief Medical Officer
HT
Heather Turner
Independent Chair of the Board
View full Avalyn Pharmaceuticals profile